Ravinder Kaur1, Matthew Morris1, Michael E Pichichero2. 1. Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York. 2. Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York michael.pichichero@rochesterregional.org.
Abstract
OBJECTIVES: To study the epidemiology of acute otitis media (AOM), especially the otitis-prone condition, during the pneumococcal conjugate vaccines 7 and 13 era. METHODS: Six hundred and fifteen children were prospectively managed from 6 to 36 months of life during a 10-year time frame (June 2006-June 2016). All clinical diagnoses of AOM were confirmed by tympanocentesis and bacterial culture of middle ear fluid. RESULTS: By 1 year of age, 23% of the children experienced ≥1 episode of AOM; by 3 years of age, 60% had ≥1 episodes of AOM, and 24% had ≥3 episodes. The peak incidence occurred at 6 to 12 months of life. Multivariable analysis of demographic and environmental data revealed a significantly increased risk of AOM associated with male sex, non-Hispanic white race, family history of recurrent AOM, day care attendance, and early occurrence of AOM. Risk factors for stringently defined (tympanocentesis-confirmed) otitis proneness, in which children suffered at least 3 episodes of AOM in a 6-month period or at least 4 within a year, were male sex, day care attendance, and family history of AOM, whereas breastfeeding in the first 6 months of life was protective. Stringently defined otitis prone children were also likely to experience their first AOM episode at a younger age. The proportion of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing AOM had dynamic changes during the past decade. CONCLUSIONS: We conclude that the epidemiology but not the risk factors for AOM have undergone substantial changes since the introduction of pneumococcal conjugate vaccines.
OBJECTIVES: To study the epidemiology of acute otitis media (AOM), especially the otitis-prone condition, during the pneumococcal conjugate vaccines 7 and 13 era. METHODS: Six hundred and fifteen children were prospectively managed from 6 to 36 months of life during a 10-year time frame (June 2006-June 2016). All clinical diagnoses of AOM were confirmed by tympanocentesis and bacterial culture of middle ear fluid. RESULTS: By 1 year of age, 23% of the children experienced ≥1 episode of AOM; by 3 years of age, 60% had ≥1 episodes of AOM, and 24% had ≥3 episodes. The peak incidence occurred at 6 to 12 months of life. Multivariable analysis of demographic and environmental data revealed a significantly increased risk of AOM associated with male sex, non-Hispanic white race, family history of recurrent AOM, day care attendance, and early occurrence of AOM. Risk factors for stringently defined (tympanocentesis-confirmed) otitis proneness, in which children suffered at least 3 episodes of AOM in a 6-month period or at least 4 within a year, were male sex, day care attendance, and family history of AOM, whereas breastfeeding in the first 6 months of life was protective. Stringently defined otitis prone children were also likely to experience their first AOM episode at a younger age. The proportion of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing AOM had dynamic changes during the past decade. CONCLUSIONS: We conclude that the epidemiology but not the risk factors for AOM have undergone substantial changes since the introduction of pneumococcal conjugate vaccines.
Authors: David P McCormick; Kristofer Jennings; Linda C Ede; Pedro Alvarez-Fernandez; Janak Patel; Tasnee Chonmaitree Journal: Int J Pediatr Otorhinolaryngol Date: 2015-12-18 Impact factor: 1.675
Authors: Steven K Brennan; David Molter; Maithilee Menezes; Katherine Dunsky; David Leonard; Judith Lieu; Keiko Hirose; Guy Hazan; Amjad Horani; Thomas Ferkol; Steven L Brody Journal: Int J Pediatr Otorhinolaryngol Date: 2020-12-31 Impact factor: 1.675
Authors: Marianne F L van den Broek; Ilke De Boeck; Filip Kiekens; An Boudewyns; Olivier M Vanderveken; Sarah Lebeer Journal: Clin Microbiol Rev Date: 2019-07-03 Impact factor: 26.132
Authors: Gijs van Ingen; Carlijn M P le Clercq; Vincent W V Jaddoe; Henriette A Moll; Liesbeth Duijts; Hein Raat; Robert J Baatenburg de Jong; Marc P van der Schroeff Journal: Clin Otolaryngol Date: 2021-02-21 Impact factor: 2.597
Authors: Scott D Hirsch; Christina L Elling; Tori C Bootpetch; Melissa A Scholes; Lena Hafrén; Sven-Olrik Streubel; Harold S Pine; Todd M Wine; Wasyl Szeremeta; Jeremy D Prager; Elisabet Einarsdottir; Ayesha Yousaf; Erin E Baschal; Sakina Rehman; Michael J Bamshad; Deborah A Nickerson; Saima Riazuddin; Suzanne M Leal; Zubair M Ahmed; Patricia J Yoon; Juha Kere; Kenny H Chan; Petri S Mattila; Norman R Friedman; Tasnee Chonmaitree; Daniel N Frank; Allen F Ryan; Regie Lyn P Santos-Cortez Journal: J Mol Med (Berl) Date: 2021-07-28 Impact factor: 4.599
Authors: Saskia Hullegie; Roderick P Venekamp; Thijs M A van Dongen; Alastair D Hay; Michael V Moore; Paul Little; Anne G M Schilder; Roger A M J Damoiseaux Journal: Pediatr Infect Dis J Date: 2021-08-01 Impact factor: 2.129